Location History:
- Suzhou, CN (2019 - 2020)
- Jiangsu, CN (2019 - 2020)
Company Filing History:
Years Active: 2019-2020
Title: Po Zou: Innovator in Pharmaceutical Crystallization
Introduction
Po Zou is a prominent inventor based in Suzhou, China, known for his significant contributions to the field of pharmaceutical crystallization. With a total of six patents to his name, he has made remarkable advancements in drug development, particularly in the area of crystalline forms of pharmaceutical compounds.
Latest Patents
One of his latest patents involves the crystalline forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl] amino} acetic acid and the processes for their preparation. This disclosure presents novel crystalline forms, including CS1, CS2, and CS8, which can be utilized in the development of drugs for treating anemia. These forms provide new options for drug formulation and hold significant value for drug development.
Another notable patent by Po Zou focuses on the crystalline forms of a sodium-glucose co-transporter inhibitor, specifically Sotagliflozin. This patent outlines the processes for preparation and use of these novel crystalline forms. The pharmaceutical compositions derived from these forms exhibit advantages such as good stability, low hygroscopicity, and cost-effectiveness, making them valuable for future drug optimization and development.
Career Highlights
Throughout his career, Po Zou has worked with reputable companies in the pharmaceutical industry, including Crystal Pharmaceutical (Suzhou) Co., Ltd. and Crystal Pharmatech Co., Ltd. His work has significantly impacted the field of drug formulation and development.
Collaborations
Po Zou has collaborated with notable professionals in the industry, including Minhua Chen and Yanfeng Zhang. These collaborations have further enhanced his contributions to pharmaceutical innovations.
Conclusion
Po Zou's innovative work in the field of pharmaceutical crystallization has led to the development of novel drug formulations that hold promise for treating various diseases. His contributions continue to shape the future of drug development and optimization.